Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T83103
(Former ID: TTDI01712)
|
|||||
Target Name |
Interleukin (IL)
|
|||||
Synonyms |
Interleukin
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Crohn disease [ICD-11: DD70] | |||||
2 | Lupus erythematosus [ICD-11: 4A40] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | PF-04236921 | Drug Info | Phase 2 | Systemic lupus erythematosus | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | PF-04236921 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | US patent application no. 2010,0158,905, Combination therapy of arthritis with tranilast. | |||||
REF 2 | ClinicalTrials.gov (NCT01405196) Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.